WILSON ALAN D reported acquisition or exercise transactions in this Form 4 filing.
Alan D. Wilson, a director of PRICE T ROWE GROUP INC, received a grant of 1,899 shares of common stock as a restricted stock unit award under the 2017 Non-Employee Director Equity Plan at $105.33 per share. His direct holdings increased to 40,664.9114 shares, with vesting tied to service, death, disability, or a change in control.
WIJNBERG SANDRA S reported acquisition or exercise transactions in this Form 4 filing.
PRICE T ROWE GROUP INC director Sandra S. Wijnberg received a grant of 1,899 shares of common stock as equity compensation. The restricted award was issued at $105.33 per share under the 2017 Non-Employee Director Equity Plan and increased her direct holdings to about 31,876 shares.
The award and accrued dividends will fully vest and become nonforfeitable upon the earliest of several events, including the day immediately prior to the next year’s annual meeting, death, determination of total and permanent disability, or a change in control, when vesting would occur immediately before that event.
Verma Richard R. reported acquisition or exercise transactions in this Form 4 filing.
PRICE T ROWE GROUP INC director Richard R. Verma reported receiving an equity award in the form of 1,899 shares of Common Stock on May 8, 2026. The award is tied to the company’s 2017 Non-Employee Director Equity Plan and was issued at $105.33 per share, matching the closing price that day.
The restricted stock unit shares and related dividends are subject to forfeiture until they vest. Vesting occurs in full upon the earliest of several events, including the day immediately prior to the next year’s Annual Meeting, death, a determination of Total and Permanent Disability, or a Change in Control. Following this grant, Verma directly holds about 4,835.2923 shares of the company’s stock.
STEVENS ROBERT J reported acquisition or exercise transactions in this Form 4 filing.
PRICE T ROWE GROUP INC director Robert J. Stevens received an equity award of 1,899 restricted stock unit shares under the 2017 Non-Employee Director Equity Plan. The award was granted at $105.33 per share and increases his direct holdings to 24,431.665 shares of common stock.
The restricted stock unit shares and accrued dividends will vest in full upon the earlier of next year’s annual meeting, his death, a determination of total and permanent disability, or immediately before a qualifying change in control.
PRICE T ROWE GROUP INC director Cynthia F. Smith received an equity award of 1,899 shares of common stock. The grant is coded as a compensation-related acquisition with no cash paid per share. The award was valued using a share price of $105.33 under the 2017 Non-Employee Director Equity Plan and is structured as restricted stock unit shares that vest upon specific events, including the day before the next annual meeting, death, total and permanent disability, or a change in control. Following this grant, Smith directly holds a total of 8,628.5939 shares.
Rominger Eileen P reported acquisition or exercise transactions in this Form 4 filing.
PRICE T ROWE GROUP INC director Eileen P. Rominger received a stock grant of 1,899 common shares on May 8, 2026. The award was issued at $105.33 per share under the 2017 Non-Employee Director Equity Plan as restricted Award Shares, with no cash paid by the director.
After this grant, Rominger directly holds 10,867 common shares. The restricted Award Shares and related accrued dividends vest in full upon the earlier of the next year’s annual meeting, death, a determination of Total and Permanent Disability, or immediately before a Change in Control.
MacLellan Robert F. reported acquisition or exercise transactions in this Form 4 filing.
PRICE T ROWE GROUP INC director Robert F. MacLellan received an equity award of 1,899 shares of common stock in the form of restricted stock units under the 2017 Non-Employee Director Equity Plan. The units were issued at $105.33 per share, matching the TROW share closing price on May 8, 2026, and were granted at no cash cost to him. These stock unit shares and related accrued dividends will fully vest upon the earliest of the first anniversary of the grant date, death, a determination of Total and Permanent Disability, or immediately before a Change in Control. Following this grant, MacLellan directly holds a total of 54,864.8316 shares of TROW common stock.
Golston Allan C. reported acquisition or exercise transactions in this Form 4 filing.
PRICE T ROWE GROUP INC director Allan C. Golston reported receiving an equity award of 1,899 shares of Common Stock with no cash paid per share. This award increased his directly held position to 4,835.2923 shares.
The footnote explains that these shares relate to Restricted Stock Units granted under the 2017 Non-Employee Director Equity Plan at a reference price of $105.33 per share, with vesting contingent on service through the next annual meeting or upon specified events such as death, total and permanent disability, or a change in control.
DUBLON DINA reported acquisition or exercise transactions in this Form 4 filing.
Price T Rowe Group director Dina Dublon received 1,899 shares of restricted common stock as a grant under the 2017 Non-Employee Director Equity Plan. The award is valued at $105.33 per share and vests in full by the next annual meeting or earlier upon death, total and permanent disability, or a change in control. After this grant, she holds 15,424.4541 shares directly and 1,890 shares indirectly through The Dina Dublon Family Trust.
BARTLETT MARK S. reported acquisition or exercise transactions in this Form 4 filing.
PRICE T ROWE GROUP INC director equity award: Director Mark S. Bartlett received a grant of 1,899 shares of common stock on May 8, 2026 under the 2017 Non-Employee Director Equity Plan at a reference price of $105.33 per share. After this award, he directly holds 35,263 common shares. These restricted shares, along with accrued dividends, will vest in full upon the earlier of the day immediately prior to the next year’s annual meeting, the director’s death, a determination of total and permanent disability, or a change in control, when vesting would occur immediately before and contingent on that event.